Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 8351 - 8375 of 10740 in total

3H-pyrazolo[4,3-d]pyrimidin-7-ol

Experimental

N-Pyridoxyl-2-Methylalanine-5-Phosphate

Experimental
Matched Name: … N-Pyridoxyl-2-Methylalanine-5-Phosphate …
Matched Iupac: … 2-[({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)amino]-2-methylpropanoic acid …

5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE

Experimental
Matched Name: … 5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE …
Matched Iupac: … -7-yl]oxy}-4-oxobutanoic acid ... 4-{[(1S,3aS,3bR,5aS,7S,9aS,9bS,11aS)-1-acetyl-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren …

1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine

Experimental

S-(2,4-dinitrophenyl)glutathione

Experimental
Matched Iupac: … (2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-[(2,4-dinitrophenyl)sulfanyl]ethyl]carbamoyl}butanoic …

anti-OX40 antibody BMS 986178

A macrocyclic peptide (BMS-986189) with activity in binding and functional assays comparable to a PD-L1 antibody.
Investigational

Sepantronium

Sepantronium is a compound that suppresses survivin expression in a dose and time-dependent manner, and causes broad-range apoptosis.
Investigational

NT-102

Investigational

Josamycin propionate

Experimental
Matched Iupac: … (2S,3S,4R,6S)-6-{[(2R,3S,4R,5R,6S)-6-{[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-(acetyloxy)-5-methoxy-9,16- ... )-5-hydroxy-2-methyloxan-3-yl]oxy}-4-hydroxy-2,4-dimethyloxan-3-yl 3-methylbutanoate ... dimethyl-2-oxo-7-(2-oxoethyl)-10-(propanoyloxy)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy}-4-(dimethylamino …

CLL1-CD33 compound chimeric antigen receptor T cells

Investigational

TALL-104

Investigational

Interferon alfa-1b

Investigational

7-methyl-7,8-dihydroguanosine-5'-diphosphate

Experimental
Matched Name: … 7-methyl-7,8-dihydroguanosine-5'-diphosphate …
Matched Iupac: … [({[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-hydroxy-2-imino-7-methyl-3,7,8,9-tetrahydro-2H-purin-9-yl)oxolan …

Cyclohexyl-Hexyl-Beta-D-Maltoside

Experimental
Matched Iupac: … (2R,3R,4S,5S,6R)-2-{[(2R,3S,4R,5R,6R)-6-[(6-cyclohexylhexyl)oxy]-4,5-dihydroxy-2-(hydroxymethyl)oxan- …

Histidyl-Adenosine Monophosphate

Experimental
Matched Iupac: … {[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]oxy}({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan …

N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine

Experimental

Phosphomethylphosphonic acid guanylate ester

Experimental
Matched Iupac: … ({[({[(2R,3S,4R,5R)-5-(2-amino-6-oxo-6,9-dihydro-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy …

N-METHYL-N-[(1R)-1-METHYL-2-PHENYLETHYL]PROP-2-EN-1-AMINE

Experimental

Adenosine-5'-[Beta, Gamma-Methylene]Tetraphosphate

Experimental
Matched Name: … Adenosine-5'-[Beta, Gamma-Methylene]Tetraphosphate …
Matched Iupac: … {[({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl) …

Pristimerin

Pristimerin is a quinone methide triterpenoid researched for its anti-cancer potential.
Investigational

EQ101

Investigational

Exon 45 specific phosphorothioate oligonucleotide

Investigational

Ethoxyquin

Investigational

Dexloxiglumide

Dexloxiglumide is a selective cholecystokinin type A (CCKA) receptor antagonist in phase III testing by Rottapharm in Europe only, as U.S. trials have been discontinued. As the D-isomer of loxiglumide, it retains all pharmacological properties of loxiglumide but is more potent.
Investigational
Matched Iupac: … (4R)-4-[(3,4-dichlorophenyl)formamido]-4-[(3-methoxypropyl)(pentyl)carbamoyl]butanoic acid …

N-Pyridoxyl-Threonine-5-Monophosphate

Experimental
Matched Name: … N-Pyridoxyl-Threonine-5-Monophosphate …
Matched Iupac: … 3-hydroxy-2-[({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)amino]butanoic acid …
Displaying drugs 8351 - 8375 of 10740 in total